ATTD: Advanced Technologies and Treatments for Diabetes

In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.They discuss:The importance of titration in successful insulin therapyBarriers to titration, including patient self-managementHow clinicians can collaborate with patients in their titration journeyThe importance of language used by cliniciansPractical tips for simplifying titration in busy clinical settingsDr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes.They discuss:When clinicians should consider insulin for patients with T2DAddressing concerns of weight gain with insulinADA/EASD recommendationsBarriers to insulin therapy and Type 2 diabetesAdvice on communication with patientsDr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use.He is joined by Dr Giulio Romeo.They discuss:The role of basal insulin in normal physiology and why it matters in Type 2 diabetesGoals of basal insulin therapyWhat makes new basal insulins differentCurrent guidelines and recommendations for basal insulin therapyAlternatives to basal insulin therapyTips for safe and effective initiation and titrationDr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. Join us as we summarize key takeaways from these thought-provoking presentations: Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. Join us as we summarize key takeaways from these thought-provoking presentations: Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews Non-invasive Glucose Monitoring – Dr. Lutz Heinemann CGM Use in Clinical Trials – Prof. Pratik Choudhary This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. Join us as we summarize key takeaways from these thought-provoking presentations: • Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel • Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell • Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard • Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Refining Care of Type 1 Diabetes – Dr. Lori Laffel Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Managing Overweight & Obesity in Type 1 Diabetes, featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes. As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman • Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown • Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Adjunct Therapies with Automated Insulin Delivery, featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes. As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 diabetes-such as SGLT-2 inhibitors and GLP-1 receptor agonists-may complement automated insulin delivery systems to optimize glycemic control and potentially improve cardiometabolic outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • ADJUST T1D Study – Design and Glycemic Outcome – Dr. Viral N. Shah (United States of America) presents the study design and early glycemic outcomes of the ADJUST T1D trial, evaluating the impact of adjunct therapies alongside automated insulin delivery. • ADJUST T1D Study – Cardiovascular Outcomes – Dr. Janet K. Snell-Bergeon • Concurrent Use of AID with SGLT-2 – Dr. Ahmad Haidar• Real-Life Data on GLP Use in Type 1 Diabetes – Associate Professor Francisco J. Pasquel This episode is an essential listen for endocrinologists, diabetologists, clinical researchers, and healthcare professionals involved in diabetes technology looking to understand emerging strategies that combine automated insulin delivery with adjunct pharmacological therapies to enhance diabetes management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year. Join us as we summarize key takeaways from these thought-provoking presentations: • Continuous and Intermittent Glucose Monitoring – Professor Jennifer Sherr (United States of America)• Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal (United States of America) • New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester (Germany) • Closed-Loop, Decision Support, and Artificial Intelligence – Dr. Mark Clements (United States of America) examines advances in automated insulin delivery systems and AI-supported diabetes management. • Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman highlights the expanding role of digital tools in diabetes prevention and care. • Technology and Pregnancy – Jennifer M. Yamamoto (Canada) reviews the use of diabetes technologies to support glucose management during pregnancy. • Diabetes Technology and Therapy in the Pediatric Age Group – Prof. David M. Maahs (United States of America) discusses technological and therapeutic advances in pediatric diabetes care. • Advances in Exercise and Nutrition as Therapy in Diabetes – Prof. Michael C. Riddell (Canada) explores the evolving role of lifestyle interventions supported by technology. • Primary Care and Diabetes Technologies and Treatments – Dr. Gregg D. Simonson (United States of America) examines how innovations in diabetes care are being integrated into primary care settings. • Use of Technologies at the Advanced Age – Dr. Anna Kahkoska (United States of America) discusses the challenges and opportunities of implementing diabetes technologies in older adults. • The Real “Real World”: Overcoming Practical Barriers and Disparities in Diabetes Technology – Dr. Ananta Addala (United States of America) highlights real-world challenges in access and implementation. • Diabetes Technology in the Hospital – Tim Hropot (Slovenia) reviews the role of diabetes technologies in inpatient care. • Impact of Diabetes Technologies on Psychosocial Outcomes – Alon Liberman (Israel) discusses how technological advances affect quality of life and psychosocial wellbeing. • Immune Intervention and Beta Cell Replacement Therapies in Type 1 Diabetes – Prof. Desmond Schatz (United States of America) reviews emerging therapeutic approaches aimed at modifying disease progression. • Obesity and Diabetes – Dr. Viral N. Shah (United States of America) examines the evolving relationship between obesity and diabetes management. • Emerging Trends in MASLD and MASH – Prof. Satish K. Garg (USA) explores new insights into metabolic liver disease and its links to diabetes. • Virtual Clinics for Diabetes Care – Prof. Satish K. Garg discusses the growing role of telemedicine and virtual care models. • New Medications for the Treatment of Diabetes – Prof. Satish K. Garg reviews emerging pharmacological therapies shaping the future of diabetes treatment. This episode is an essential listen for endocrinologists, diabetologists, researchers, and healthcare professionals in diabetes care looking to stay up to date with the most important technological, therapeutic, and clinical developments presented at ATTD 2026. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Debate: HbA1c and Not CGM Should Be the Gold Standard to Evaluate Glucose Control, featuring a dynamic exchange of perspectives on the most accurate method for assessing glucose control in diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Pro – Dr. Elizabeth Selvin Con – Dr. Richard M. Bergenstal Moderator – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking insights into the ongoing debate between HbA1c and Continuous Glucose Monitoring (CGM) in evaluating glucose control. Gain a deeper understanding of the arguments for and against each method, and the implications for diabetes management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into What Else Is New? Featuring the latest advancements in the treatment and monitoring of Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Adjunctive Treatment with GLP/GIPS for Patients with Type 1 Diabetes: Consensus Report and Guidelines for Safer Use – Prof. Satish Garg An International Consensus on Screening and Monitoring Early-stage Type 1 Diabetes: A Roadmap to European Implementation – Online First Release – Dr. Sufyan Hussain This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the newest consensus guidelines and the future of screening and treatment strategies for Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into The Use of Technology in Treating Type 2 Diabetes, featuring cutting-edge insights into how technological advancements are transforming diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: Using Apps to Support Management of Type 2 Diabetes — Prof. Julia Mader Connected Pens in Type 2 Diabetes — Prof. Concetta Irace CGM in Type 2 Diabetes — Dr. J. Hans DeVries Automated Insulin Delivery in Type 2 Diabetes — Prof. Yves Reznik This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking to stay ahead of the curve on the integration of technology into Type 2 diabetes treatment. Get the latest on how apps, connected devices, CGM, and automated insulin delivery systems are shaping modern care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Real Life Use of Continuous Glucose Monitoring (CGM), featuring an in-depth exploration of CGM's expanding role in diabetes management across various patient populations. Join us as we summarize key takeaways from these thought-provoking presentations: CGM Frequency Use in Type 2 Diabetes — Prof. Satish Garg CGM for Prediabetes — Dr. Viral N Shah CGM in Individuals Without Diabetes — Dr. Smadar Shilo Adapting CGM Reports for The Use in Real Life — Dr. Richard M. Bergenstal This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the latest CGM applications, offering insights into real-world utilization, practical reporting, and implications for a broader range of patients. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Scientific Parallel Session 01: Screening and Treatment Options for Delaying Onset of Type 1 Diabetes, featuring the latest research and clinical perspectives on early detection, risk stratification, and preventive interventions in Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: • Screening Programs for Type 1 Diabetes in the US: From Research to Standard of Care – Prof. Michael J. Haller (United States of America) • Could CGM Replace Antibodies Screening? – Prof. Boris Kovatchev, PhD (USA) • Is It Time to Re-Evaluate Our Recommendations for Screening the General Population for Risk for Type 1 Diabetes? – Prof. Desmond Schatz, MD (United States of America) • Cost Effectiveness of Screening and Immune Interventions in Type 1 – Prof. Shweta Mital (Canada) This episode is an essential listen for endocrinologists, diabetologists, pediatric specialists, and diabetes researchers looking to better understand the evolving landscape of Type 1 diabetes screening strategies and preventive therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Transforming Diabetes Management with Artificial Intelligence (AI), featuring cutting-edge research on how AI-driven technologies are reshaping personalized diabetes care and automated insulin delivery. Join us as we summarize key takeaways from these thought-provoking presentations: • Combining Digital Twins and LLMs for Advanced Personalized Insulin Therapy in Type 1 Diabetes – Dr. Giacomo Cappon • A Week of Automated Insulin Delivery Used to Titrate Basal Insulin in Type 2 Diabetes – Dr. Heman Shakeri • Fully Automated Closed-Loop Based on Artificial Intelligence – Prof. Marc D. Breton This episode is an essential listen for clinicians, endocrinologists, diabetes researchers, and digital health professionals looking to understand the evolving role of artificial intelligence in optimizing insulin therapy and automated diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Hot from the Oven, featuring the latest advancements in diabetes care and treatments. Join us as we summarize key takeaways from these thought-provoking presentations: • Evaluation of CGM-based Insulin Dose Guidance System in People with Type 1 and Type 2 Diabetes: Single Arm Feasibility Study - Prof. Andrej Janež • FREEDM2 RCT: New Insights into CGM with Basal Insulin in T2DM - Dr. Emma G. Wilmot • Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults Initiating Treatment Early in the Course of Type 2 Diabetes: Results from SURPASS-Early Study after 2 Years of Treatment - Prof. Stefano Del Prato • The Progress Study: Phase 1/2 Clinical Trial of KRIYA-839, a Novel AAV Gene Therapy for Adults with Type 1 Diabetes - Dr. Jeremy Pettus This episode is an essential listen for healthcare professionals in endocrinology and diabetes care, looking to stay up-to-date with cutting-edge research and treatment advancements. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. attd.kenes.com 

We’re excited to launch the ATTD 2026 Conference Catch-Up, a brand-new, AI-powered podcast designed for healthcare professionals who want to stay ahead in diabetes care. Whether you’re attending ATTD 2026 in Barcelona or following from afar, this podcast ensures you don’t miss a thing. Using AI-driven podcast generation, we’ll bring you key takeaways from select sessions, breaking down the latest in screening and treatment of T1D, CGM, new technologies, AI use, weight management in diabetes, and more. Get ready for insightful summaries! ATTD 2026 is taking place on 11-14 March, in Barcelona, Spain. It's the ultimate conference to discover the latest worldwide research, devices, therapies and developments in the diabetes field. Find out more: https://attd.kenes.com/ 

In this episode of ATTD Tech Connect, host Julie Taplin and Dr Anna Korsgaard Berg discuss skin care management for people living with diabetes using diabetes technology.They discuss:The different skin layers and how they can be impacted by the use of diabetes technologyHow poor skin integrity directly affects glucose outcomesThings to look out for and ask as a clinicianSome practical prevention strategiesLatest research on using ultrasounds to measure skin depthDr Anna Korsgaard Berg is a Diabetes researcher at Steno Diabetes Center, Copenhagen and works in Pediatrics at Herlev Hospital.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professor Katarzyna Cyranka, clinical psychologist and psychotherapist, discuss the important topic of burden and quality of life related to diabetes and diabetes technologies for people living with diabetes.They discuss:Distinguishing diabetes distress from diabetes burnoutPossible sources of diabetes distressThe role of diabetes technology, especially AHCL, in reducing diabetes distressSigns to watch out for as clinicians, nurses, and educatorsTools to assist in naming and identifying sources of diabetes distressProfessor Katarzyna Cyranka is a clinical psychologist and certified psychotherapist, based in Krakow, Poland. This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professors Tadej Battelino and Klemen Dovč discuss the importance of multi-disciplinary diabetes care, and offer solutions to the common challenges that can crop up when managing a diabetes team.They discuss:Common challenges such as time constraints, busy clinics, and comorbiditiesSolutions such as effective communication, regular meetings, and the use of AI in automating workloadsImportance of synergy across various departments and professions within diabetes careProfessor Tadej Battelino is Co-Chair of ATTD and Chair of the International Diabetes Federation Europe. Professor Klemen Dovč is an Associate professor in the Faculty of Medicine at the University of Ljubljana.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Amy Jolley, Lead Diabetes Specialist Dietician, discuss exercise management in diabetes and the ways the MiniMed™ 780G system supports people with diabetes and healthcare professionals.They discuss:Barriers to exercise for people living with diabetesThe different glucose responses to aerobic and anaerobic exercise The features and benefits of AID systems compared with MDI therapy Advice on bolusing, fuelling during exercise, pre and post meal suggestions and ways to help reduce hyposAmy Jolley is a Lead Diabetes Specialist Dietician for the young adult and transition services at Salford Care Organisation, NHS, in the UK.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Ashley Mehnert, Diabetes Clinical Nurse Specialist, break down the Smart MDI system and its benefits.They discuss:What exactly is Smart MDI systemHow it differentiates from standard MDI therapyBenefits, including visibility to insulin useThe actionable alerts and clinical impactAshley Mehnert is a Diabetes Clinical Nurse Specialist working in the NHS in the north east of England.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Maya Laron Hirsh, Clinical Dietician, discuss managing meals with the MiniMed™ 780G system.They discuss:Carb countingWhat to do if you miss a bolusHow to handle high fat and/or protein mealsMaya Laron Hirsh is a Clinical Dietician, Head of Diabetes & Obesity Nutrition Department at Sheba Medical Center, and Chair of the Diabetes Forum, Israeli Dietetic Association. She specializes in nutritional therapy for automated insulin delivery systems and has worked closely with people with diabetes using the 780G system.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guests explore how healthcare professionals can make the most of CareLink™ Clinic - a powerful tool for supporting healthcare professionals and people living with Type 1 diabetes.They discuss:An overview of the CareLink™ Clinic reportsThe three-Step Methodology for Healthcare ProfessionalsUsing CareLink™ Clinic reports for Patient EducationDietary Insights and CareLink™ Clinic Douha Almajaly is a Diabetes Educator, and Maheen Ahmed is a Clinical Dietician, both from Sidra Medicine. Professor Goran Petrovski is the Medical Director for Medtronic Diabetes and an Endocrinologist & Diabetologist working at Sidra Medicine.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

How can diabetes educators be supported in the fast-moving world of diabetes technology?In the first episode of ATTD Tech Connect, host Julie Taplin discusses the need for an educational pathway for diabetes educators when training PwD on the MiniMed™ 780G system with Geraldine Gallen.They discuss:Why the pathway is neededThe four key components of the pathwayThe barriers to providing diabetes educator trainingImplementing the pathway at King’s College HospitalGeraldine Gallen is a Type 1 Service Lead and Diabetes Nurse Consultant at Kings College Hospital, London. She is UK​ and Vice Chair of the Association of British Clinical Diabetologists (ABCD) – Diabetes Technology Network (DTN), UK​. This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.Minimed Medtronic Academy and WePartner OnlineMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Diabetes technology is evolving fast. In ATTD Tech Connect, we show how it can help healthcare professionals — nurses, educators, and dieticians — improve therapy and daily life for people living with diabetes.In this new series sponsored by Medtronic Diabetes, you’ll learn from diverse clinical experience and evidence-based guidance from leaders in diabetes care, tailored for those who support patients every day.Hosted by Julie Taplin, Dietician and Medtronic Diabetes Education Specialist, the series will explore practical strategies to reduce burden, support meal planning and exercise, and optimize outcomes in real-world care.Make sure you’re subscribed to the ATTD Podcast feed today. Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Minimed Medtronic Academy and WePartner Online

In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek.They discuss:High-Risk Pregnancies and Current Gaps in CareChallenges in Type 2 Diabetes ResearchImpact of CGM Technology During PregnancyPre-Pregnancy and Pregnancy Care for Type 2 DiabetesThird Trimester and Delivery ConsiderationsEarly Adoption of Hybrid Closed LoopsDr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event.She is joined by Dr Grenye O’Malley.They discuss:How glucose patterns and insulin needs change postpartumGDM as a spectrum to Type 2 diabetesCGM use for early detection of type 2 diabetes after GDMStrategies for transitioning from intensive pregnancy care to postpartum follow-upGrenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.They discuss:Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatiguePractical troubleshooting strategies for clinicians and patientsThe role of education and support in overcoming CGM-related challengesSarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is the Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.They discuss:How CGM improves maternal and neonatal outcomesKey clinical trials including the CONCEPTT trialEvolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.They discuss:How AI and CGM technology is transforming diabetes and metabolic health managementAI identification of diabetes subtypes and personalised interventionsImpact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellnessPotential of AI-driven tools for early intervention and improved health outcomesDr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.They cover:The Role of AI in Continuous Glucose MonitoringChallenges and Potential of AI in Diabetes ManagementAI and CGM for Young People with DiabetesPotential for AI to instigate behaviour changeDr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.They explore a wide range of topics including:General challenges in managing diabetesAdjusting insulin doses for better controlTime in tight range (TITR) and insulin managementFasting and diabetes managementImpact of GLP-1 on Type 1 diabetes managementChallenges of switching to weekly insulin injectionsDefining and managing hypoglycemia riskPersonalized diabetes management approachesDiabetes management in athletesDr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.They cover:Challenges and solutions in real-world insulin therapyHow personalized strategies improve patient outcomesLessons learned from patient-provider collaborationsFuture opportunities for enhancing patient engagement and adherenceHow to balance diabetes care with lifestyle choicesChristel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.They cover:The latest clinical trials and guidelinesNew insulin formationsSmart delivery technologiesThe potential of GLP-1 and GIP hormonesAdvice on lowering treatment burden and improving the quality of life for those living with diabetesLucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.This is an accredited activity that gives you 1 CME/CPD credit.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by Dr. Egils Bogdanovics to hear perspectives on how to effectively combine long-acting insulin with other diabetes treatments.They discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.Dr. Egils Bogdanovics is an Assistant Clinical Professor of Medicine at the University of Connecticut. He’s Medical Director at the Charlotte Hungerford Hospital Diabetes Center, and a diplomate of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.Their conversation provides you with step-by-step guidance on dose titration and adjustments, monitoring and managing adverse effects, and strategies for patient education and engagement during initiation. Aimée draws from her clinical experience working with patients in a non-judgemental manner, encouraging better collaboration between patient and provider.Aimée José is Principal Clinical Educator at Codex Health. She’s a highly skilled Diabetes Educator with expertise in clinical diabetes care & technology.Visit the Insulin Knowledge Hub on the Unlok Education website for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care Practice.If you'd like to dive deeper into today’s topic, don’t miss our workshop video: “Patient Selection and Initiation of Long-Acting Insulin Therapy” on the ATTD Education Portal, where Dr. Rodolfo Galindo, Dr. Amit Gupta, Dr. Medha Munshi, Prof. Concetta Irace, and Prof. Raffaella Buzzetti explore two real-world case studies and share expert strategies to guide clinical decisions.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.They explore how long-acting insulin can improve blood glucose levels, reduce the burden of daily injections, and simplify insulin management for the person with diabetes.Diana Isaacs is a diabetes advocate and speaker. She’s a Director in Education & Training in Diabetes Technology at the Cleveland Clinic, and she’s also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).If you’d like to dive deeper into today’s topic, don’t miss our CME/CPD accredited e-learning course, titled Breaking New Ground: Once-Weekly Insulin. The session delves into the evolution of long-acting insulin therapy and introduces groundbreaking once-weekly formulations. 1 CME/CPD Credit available.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the first episode of ATTD’s brand new series on long-acting insulin, join our host Ginger Vieira and guest Jennifer Okemah, RD, CDCES, as they provide an overview of the role of long-acting insulin in diabetes management, the potential benefits, and the evolution of the different formulations available today.Jennifer Okemah has been a Registered Dietitian (RD)/Nutritionist since 2005 and a Certified Diabetes Care and Education Specialist (CDCES) since 2007.She has an additional certification as a Sports Specialist in Dietetics as well as being Board Certified in Advanced Diabetes Management.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

What’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.Hosted by Ginger Vieira and powered by ATTD, this series brings you real conversations with CDCESs, PharmDs, pediatric endocrinologists, and people living with diabetes.We’ll dive into the latest trends, explore clinical benefits, discuss patient selection strategies, and share real-world success stories to help you apply new insights in your practice.Subscribe now and join us as we uncover how long-acting insulin is shaping the future of diabetes management.

In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.Join us as we summarize key takeaways from these thought-provoking presentations:Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria SalemNew Strategies for Curative Therapies for Diabetes – Prof. Stefan BornsteinUpdate on Efforts to Interdict Type 1 Diabetes – Dr. Desmond SchatzThis episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.Join us as we summarize key takeaways from these thought-provoking presentations:View – Dr. Anders CarlsonCounterview – Dr. Jeremy Pettus Rebuttal by Speaker Presenting View – Dr. Anders CarlsonRebuttal by Speaker Presenting Counterview – Dr. Jeremy PettusThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.Join us as we summarize key takeaways from these thought-provoking presentations:View – Prof. Jennifer SherrCounterview – Dr. Steven EdelmanRebuttal by Speaker Presenting View – Prof. Jennifer SherrRebuttal by Speaker Presenting Counterview – Dr. Steven EdelmanThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to understand the potential clinical impact of continuous ketone monitoring in diabetes management, its role in preventing complications, and its future integration into patient care.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.Join us as we summarize key takeaways from these thought-provoking presentations:Artificial Intelligence (AI) for Diabetes Treatment: A Next Step of Systematic Review and Network Meta-Analyses? – Prof. Oliver SchnellData-Driven Machine Learning: Unlocking the Future of Closed-Loop Diabetes Care – Prof. Yao QinMultiomics Biomarkers for Improved Diagnosis of Endocrine Hypertension – Prof. Maria-Christina ZennaroThis episode is an essential listen for endocrinologists, diabetes specialists, data scientists, and healthcare professionals looking to explore the latest advancements in AI and machine learning technologies, and how they are shaping the future of personalized healthcare, diabetes management, and diagnostic accuracy.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and necessity of placebo-controlled trials in type 1 diabetes research, with a focus on adaptive trial designs and the future of treatment testing.Join us as we summarize key takeaways from these thought-provoking presentations:Yes, We Should Continue with Placebo – Prof. Colin DayanNo, We Should Use Only Active (Approved) Control – Dr. Laura JacobsenRebuttal by Speaker Presenting the Case for 'Yes' – Prof. Colin DayanRebuttal by Speaker Presenting the Case for 'No' – Dr. Laura JacobsenThis episode is an essential listen for researchers, clinicians, and diabetes specialists interested in the future of clinical trial design, the ethical considerations in testing new treatments, and the evolving landscape of type 1 diabetes research.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Updates on Diabetes Management and Female Health, featuring discussions on gender-specific challenges in diabetes care, the role of technology and AI in addressing these disparities, and the need for personalized treatment approaches for women with diabetes.Join us as we summarize key takeaways from these thought-provoking presentations: Leveraging Technology to Address Gender Differences in Diabetes – Prof. Eda Cengiz The Role of Estradiol in Energy and Glucose-Insulin Homeostasis – Dr. Lia Bally Impact of Sex on the Control of Type 2 Diabetes – Prof. Chiara FabrisSex Differences in Diabetes Management in the Primary Care Setting – Dr. Natalie BelliniSex Differences in Cardiovascular Risk Factors in Youth with Type 1 Diabetes – Dr. Darja Šmigoc SchweigerThis episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers who are looking to gain insights into the latest gender-specific approaches in diabetes management and how to leverage technology to improve patient outcomes for women with diabetes.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CGM, and personalized approaches to managing type 2 diabetes and pre-diabetes, with a focus on improving patient outcomes.Join us as we summarize key takeaways from these thought-provoking presentations:SGLT2i Use in Young People Following Approval by FDA and EMA in Type 2 Diabetes – Dr. Lori LaffelDo Different Types of Prediabetes Require Different Types of Prevention Approaches? – Dr. Viswanathan MohanUse of CGM in Pre-Type 2 Diabetes – Prof. Viral ShahThis episode is an essential listen for endocrinologists, diabetes care specialists, healthcare providers, and researchers focusing on innovative, patient-centered approaches to managing type 2 diabetes and pre-diabetes, aimed at improving both clinical outcomes and patient experiences.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com